Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg‐negative, HBcAb‐positive rheumatoid arthritis patients: A long‐term, real‐world observation-Reference-Cited by-同舟云学术

Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg‐negative, HBcAb‐positive rheumatoid arthritis patients: A long‐term, real‐world observation

Published:2019-05-22 Issue: Volume: Page:
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Chen Yi‐Ming¹²³⁴,Chen Hsin‐Hua¹²³⁴,Huang Wen‐Nan³⁴,Chen Yi‐Hsing³⁴,Hsieh Tsu‐Yi⁴⁵,Yang Sheng‐Shun³⁶,Lan Joung‐Liang⁷⁸⁹,Chen Der‐Yuan⁷⁸⁹^ORCID

Affiliation:

1. Department of Medical Research Taichung Veterans General Hospital Taichung Taiwan

2. Institute of Biomedical Science and Rong Hsing Research Center for Translational Medicine National Chung Hsing University Taichung Taiwan

3. Faculty of Medicine National Yang Ming University Taipei Taiwan

4. Division of Allergy, Immunology and Rheumatology Taichung Veterans General Hospital Taichung Taiwan

5. Department of Medical Education Taichung Veterans General Hospital Taichung Taiwan

6. Division of Gastroenterology and Hepatology Taichung Veterans General Hospital Taichung Taiwan

7. Rheumatology and Immunology Center China Medical University Hospital Taichung Taiwan

8. Translational Medicine Laboratory, Rheumatology and Immunology Center China Medical University Hospital Taichung Taiwan

9. School of Medicine China Medical University Taichung Taiwan

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.13582

Reference41 articles.

1. Hepatitis B virus infection;Dienstag JL;N Engl J Med,2008

2. Hepatitis B e antigen and antibody in asymptomatic Chinese with hepatitis B surface antigenemia in Taiwan;Sung JL;Gastroenterol Jpn,1982

3. Slow decline of hepatitis B burden in general population: results from a population‐based survey and longitudinal follow‐up study in Taiwan;Chen C‐L;J Hepatol,2015

4. Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies;Calabrese LH;Ann Rheum Dis,2006

5. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody‐positive rheumatoid arthritis patients undergoing anti‐tumor necrosis factor alpha therapy;Lan JL;Ann Rheum Dis,2011

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg‐negative anti‐HBc‐positive patients? Meta‐analysis and decision curve analysis;Liver International;2024-08-29

2. ÇÖZÜLMÜŞ HEPATİT B ENFEKSİYONLU VE ROMATİZMAL HASTALIĞI OLAN BİREYLERDE RİTUKSİMAB KULLANIMININ HEPATİT B REAKTİVASYONU ÜZERİNE ETKİSİ: TEK MERKEZLİ BİR ÇALIŞMA;İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi;2024-06-20

3. Actualización de las Guías para el Tratamiento Farmacológico de la Artritis Reumatoide del Colegio Mexicano de Reumatología 2023;Reumatología Clínica;2024-05

4. Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023;Reumatología Clínica (English Edition);2024-05

5. A Review of Hepatitis B Reactivation Risk on Immunosuppressants with a Focus on Newer Immunomodulators;Current Hepatology Reports;2024-02-28